These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 1351426)
1. Postnatal changes in AMPA receptor regulation by phospholipase A2 treatment of synaptic membranes: temporally differential effects on agonist and antagonist binding. Massicotte G; Bernard J; Baudry M Brain Res Dev Brain Res; 1992 Apr; 66(2):203-8. PubMed ID: 1351426 [TBL] [Abstract][Full Text] [Related]
2. Opposite effects of phospholipase A2 on [3H]AMPA binding in adult and neonatal membranes. Baudry M; Massicotte G; Hauge S Brain Res Dev Brain Res; 1991 Aug; 61(2):265-7. PubMed ID: 1661214 [TBL] [Abstract][Full Text] [Related]
4. Modulation of the AMPA receptor by phospholipase A2: effect of the antidepressant trimipramine. Bernard J; Ohayon M; Massicotte G Psychiatry Res; 1994 Feb; 51(2):107-14. PubMed ID: 7912839 [TBL] [Abstract][Full Text] [Related]
5. Modulation of DL-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)/quisqualate receptors by phospholipase A2 treatment. Massicotte G; Baudry M Neurosci Lett; 1990 Oct; 118(2):245-8. PubMed ID: 2177177 [TBL] [Abstract][Full Text] [Related]
6. Effects of thiol-reagents on [3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to rat telencephalic membranes. Terramani T; Kessler M; Lynch G; Baudry M Mol Pharmacol; 1988 Aug; 34(2):117-23. PubMed ID: 2901029 [TBL] [Abstract][Full Text] [Related]
7. Increasing binding affinity of agonists to glutamate receptors increases synaptic responses at glutamatergic synapses. Shahi K; Baudry M Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6881-5. PubMed ID: 1379724 [TBL] [Abstract][Full Text] [Related]
8. Modulation of DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/quisqualate receptors by phospholipase A2: a necessary step in long-term potentiation? Massicotte G; Vanderklish P; Lynch G; Baudry M Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1893-7. PubMed ID: 1848014 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the binding of [3H]NS 257, a novel competitive AMPA receptor antagonist, to rat brain membranes and brain sections. Nielsen EO; Johansen TH; Wätjen F; Drejer J J Neurochem; 1995 Sep; 65(3):1264-73. PubMed ID: 7543932 [TBL] [Abstract][Full Text] [Related]
10. Phospholipase A2 down-regulates the affinity of [3H]AMPA binding to rat cortical membranes. Dev KK; Honoré T; Henley JM J Neurochem; 1995 Jul; 65(1):184-91. PubMed ID: 7540662 [TBL] [Abstract][Full Text] [Related]
11. Regional decreases in alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid ([3H]AMPA) and 6-[3H]cyano-7-nitroquinoxaline-2,3-dione ([3H]CNQX) binding in response to chronic low-level lead exposure: reversal versus potentiation by chronic dopamine agonist treatment. McCoy L; Richfield EK; Cory-Slechta DA J Neurochem; 1997 Dec; 69(6):2466-76. PubMed ID: 9375679 [TBL] [Abstract][Full Text] [Related]
12. Characterization and regulation of a high affinity [3H]CNQX labelled AMPA receptor in rat neocortex. Lanius RA; Shaw C Brain Res Mol Brain Res; 1992 Oct; 15(3-4):256-62. PubMed ID: 1359375 [TBL] [Abstract][Full Text] [Related]
13. Autoradiographic characterization and localization of quisqualate binding sites in rat brain using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione: comparison with (R,S)-[3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites. Nielsen EO; Drejer J; Cha JH; Young AB; Honoré T J Neurochem; 1990 Feb; 54(2):686-95. PubMed ID: 1967632 [TBL] [Abstract][Full Text] [Related]
14. Non-NMDA glutamate receptor antagonist 3H-CNOX binds with equal affinity to two agonist states of quisqualate receptors. Honore T; Drejeŕ J; Nielsen EO; Nielsen M Biochem Pharmacol; 1989 Oct; 38(19):3207-12. PubMed ID: 2573355 [TBL] [Abstract][Full Text] [Related]
15. CNQX binding to non-NMDA glutamate receptors in canine cerebro-cortical crude synaptosomal membranes: pharmacological characterization and comparison of binding parameters in dogs with congenital portosystemic encephalopathy and control dogs. Maddison JE; Watson WE; Johnston GA Metab Brain Dis; 1992 Mar; 7(1):35-44. PubMed ID: 1376856 [TBL] [Abstract][Full Text] [Related]
16. Multiple states of rat brain (RS)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors as revealed by quantitative autoradiography. Cha JH; Makowiec RL; Penney JB; Young AB Mol Pharmacol; 1992 May; 41(5):832-8. PubMed ID: 1375315 [TBL] [Abstract][Full Text] [Related]
17. Bidirectional modulation of AMPA receptor properties by exogenous phospholipase A2 in the hippocampus. Chabot C; Gagné J; Giguère C; Bernard J; Baudry M; Massicotte G Hippocampus; 1998; 8(3):299-309. PubMed ID: 9662143 [TBL] [Abstract][Full Text] [Related]
18. Developmental changes in depolarization-mediated AMPA receptor modifications and potassium-induced long-term potentiation. Chabot C; Bernard J; Normandin M; Ohayon M; Baudry M; Massicotte G Brain Res Dev Brain Res; 1996 May; 93(1-2):70-5. PubMed ID: 8804693 [TBL] [Abstract][Full Text] [Related]
19. Binding of the new radioligand (S)-[3H]AMPA to rat brain synaptic membranes: effects of a series of structural analogues of the non-NMDA receptor agonist willardiine. Hawkins LM; Beaver KM; Jane DE; Taylor PM; Sunter DC; Roberts PJ Neuropharmacology; 1995 Apr; 34(4):405-10. PubMed ID: 7566471 [TBL] [Abstract][Full Text] [Related]
20. Autoradiographic characterization of the non-N-methyl-D-aspartate binding sites in human cerebellum using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione. Hatziefthimiou A; Mitsacos A; Kouvelas ED J Neurosci Res; 1994 Feb; 37(3):392-7. PubMed ID: 7909852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]